Sterile Infusions Compounding Pharmacy Market, Global Outlook and Forecast 2022-2028

June 2022 | 101 pages | ID: SE32FF8DD6F9EN
Market Monitor Global

Abstracts

There’s a higher risk of infection or serious problems if contaminants get into the medication. So, sterile compounds are made in a special environment with additional requirements to minimize this risk.

This report contains market size and forecasts of Sterile Infusions Compounding Pharmacy in Global, including the following market information:

Global Sterile Infusions Compounding Pharmacy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sterile Infusions Compounding Pharmacy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-infectives Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sterile Infusions Compounding Pharmacy include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sterile Infusions Compounding Pharmacy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sterile Infusions Compounding Pharmacy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sterile Infusions Compounding Pharmacy Market Segment Percentages, by Type, 2021 (%)

• Anti-infectives
• Blood Factors
• Immunotherapies
• Others

Global Sterile Infusions Compounding Pharmacy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sterile Infusions Compounding Pharmacy Market Segment Percentages, by Application, 2021 (%)

• Consumers Aged 18 and Younger
• Consumers Aged 19 to 44
• Consumers Aged 45 to 64
• Consumers Aged 65 and Older

Global Sterile Infusions Compounding Pharmacy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sterile Infusions Compounding Pharmacy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sterile Infusions Compounding Pharmacy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sterile Infusions Compounding Pharmacy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Baxter
• B. Braun
• Fresenius Kabi
• Kelun Pharma
• Otsuka Pharmaceutical
• JW Pharmaceutical
• Pfizer
• Teva Pharmaceutical
• Haisco Pharmaceutical Group
• King York
• Cisen
• Lummy
• Grand Life Sciences
• Medisan
• BBCA Pharmaceutical
• Biokin Pharmaceutical
• Xi'an Libang Pharmaceutical
• Lionco Pharmaceutical
• China Meheco Kangli

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sterile Infusions Compounding Pharmacy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sterile Infusions Compounding Pharmacy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STERILE INFUSIONS COMPOUNDING PHARMACY OVERALL MARKET SIZE

2.1 Global Sterile Infusions Compounding Pharmacy Market Size: 2021 VS 2028
2.2 Global Sterile Infusions Compounding Pharmacy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sterile Infusions Compounding Pharmacy Players in Global Market
3.2 Top Global Sterile Infusions Compounding Pharmacy Companies Ranked by Revenue
3.3 Global Sterile Infusions Compounding Pharmacy Revenue by Companies
3.4 Top 3 and Top 5 Sterile Infusions Compounding Pharmacy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sterile Infusions Compounding Pharmacy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sterile Infusions Compounding Pharmacy Players in Global Market
  3.6.1 List of Global Tier 1 Sterile Infusions Compounding Pharmacy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sterile Infusions Compounding Pharmacy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sterile Infusions Compounding Pharmacy Market Size Markets, 2021 & 2028
  4.1.2 Anti-infectives
  4.1.3 Blood Factors
  4.1.4 Immunotherapies
  4.1.5 Others
4.2 By Type - Global Sterile Infusions Compounding Pharmacy Revenue & Forecasts
  4.2.1 By Type - Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2022
  4.2.2 By Type - Global Sterile Infusions Compounding Pharmacy Revenue, 2023-2028
  4.2.3 By Type - Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sterile Infusions Compounding Pharmacy Market Size, 2021 & 2028
  5.1.2 Consumers Aged 18 and Younger
  5.1.3 Consumers Aged 19 to
  5.1.4 Consumers Aged 45 to
  5.1.5 Consumers Aged 65 and Older
5.2 By Application - Global Sterile Infusions Compounding Pharmacy Revenue & Forecasts
  5.2.1 By Application - Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2022
  5.2.2 By Application - Global Sterile Infusions Compounding Pharmacy Revenue, 2023-2028
  5.2.3 By Application - Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sterile Infusions Compounding Pharmacy Market Size, 2021 & 2028
6.2 By Region - Global Sterile Infusions Compounding Pharmacy Revenue & Forecasts
  6.2.1 By Region - Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2022
  6.2.2 By Region - Global Sterile Infusions Compounding Pharmacy Revenue, 2023-2028
  6.2.3 By Region - Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
  6.3.2 US Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.3.3 Canada Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.3.4 Mexico Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
  6.4.2 Germany Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.4.3 France Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.4.4 U.K. Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.4.5 Italy Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.4.6 Russia Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.4.7 Nordic Countries Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.4.8 Benelux Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
  6.5.2 China Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.5.3 Japan Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.5.4 South Korea Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.5.5 Southeast Asia Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.5.6 India Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
  6.6.2 Brazil Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.6.3 Argentina Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sterile Infusions Compounding Pharmacy Revenue, 2017-2028
  6.7.2 Turkey Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.7.3 Israel Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.7.4 Saudi Arabia Sterile Infusions Compounding Pharmacy Market Size, 2017-2028
  6.7.5 UAE Sterile Infusions Compounding Pharmacy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Baxter
  7.1.1 Baxter Corporate Summary
  7.1.2 Baxter Business Overview
  7.1.3 Baxter Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.1.4 Baxter Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.1.5 Baxter Key News
7.2 B. Braun
  7.2.1 B. Braun Corporate Summary
  7.2.2 B. Braun Business Overview
  7.2.3 B. Braun Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.2.4 B. Braun Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.2.5 B. Braun Key News
7.3 Fresenius Kabi
  7.3.1 Fresenius Kabi Corporate Summary
  7.3.2 Fresenius Kabi Business Overview
  7.3.3 Fresenius Kabi Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.3.4 Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Kabi Key News
7.4 Kelun Pharma
  7.4.1 Kelun Pharma Corporate Summary
  7.4.2 Kelun Pharma Business Overview
  7.4.3 Kelun Pharma Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.4.4 Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.4.5 Kelun Pharma Key News
7.5 Otsuka Pharmaceutical
  7.5.1 Otsuka Pharmaceutical Corporate Summary
  7.5.2 Otsuka Pharmaceutical Business Overview
  7.5.3 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.5.4 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.5.5 Otsuka Pharmaceutical Key News
7.6 JW Pharmaceutical
  7.6.1 JW Pharmaceutical Corporate Summary
  7.6.2 JW Pharmaceutical Business Overview
  7.6.3 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.6.4 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.6.5 JW Pharmaceutical Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.7.4 Pfizer Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Teva Pharmaceutical
  7.8.1 Teva Pharmaceutical Corporate Summary
  7.8.2 Teva Pharmaceutical Business Overview
  7.8.3 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.8.4 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.8.5 Teva Pharmaceutical Key News
7.9 Haisco Pharmaceutical Group
  7.9.1 Haisco Pharmaceutical Group Corporate Summary
  7.9.2 Haisco Pharmaceutical Group Business Overview
  7.9.3 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.9.4 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.9.5 Haisco Pharmaceutical Group Key News
7.10 King York
  7.10.1 King York Corporate Summary
  7.10.2 King York Business Overview
  7.10.3 King York Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.10.4 King York Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.10.5 King York Key News
7.11 Cisen
  7.11.1 Cisen Corporate Summary
  7.11.2 Cisen Business Overview
  7.11.3 Cisen Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.11.4 Cisen Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.11.5 Cisen Key News
7.12 Lummy
  7.12.1 Lummy Corporate Summary
  7.12.2 Lummy Business Overview
  7.12.3 Lummy Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.12.4 Lummy Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.12.5 Lummy Key News
7.13 Grand Life Sciences
  7.13.1 Grand Life Sciences Corporate Summary
  7.13.2 Grand Life Sciences Business Overview
  7.13.3 Grand Life Sciences Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.13.4 Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.13.5 Grand Life Sciences Key News
7.14 Medisan
  7.14.1 Medisan Corporate Summary
  7.14.2 Medisan Business Overview
  7.14.3 Medisan Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.14.4 Medisan Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.14.5 Medisan Key News
7.15 BBCA Pharmaceutical
  7.15.1 BBCA Pharmaceutical Corporate Summary
  7.15.2 BBCA Pharmaceutical Business Overview
  7.15.3 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.15.4 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.15.5 BBCA Pharmaceutical Key News
7.16 Biokin Pharmaceutical
  7.16.1 Biokin Pharmaceutical Corporate Summary
  7.16.2 Biokin Pharmaceutical Business Overview
  7.16.3 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.16.4 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.16.5 Biokin Pharmaceutical Key News
7.17 Xi'an Libang Pharmaceutical
  7.17.1 Xi'an Libang Pharmaceutical Corporate Summary
  7.17.2 Xi'an Libang Pharmaceutical Business Overview
  7.17.3 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.17.4 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.17.5 Xi'an Libang Pharmaceutical Key News
7.18 Lionco Pharmaceutical
  7.18.1 Lionco Pharmaceutical Corporate Summary
  7.18.2 Lionco Pharmaceutical Business Overview
  7.18.3 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.18.4 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.18.5 Lionco Pharmaceutical Key News
7.19 China Meheco Kangli
  7.19.1 China Meheco Kangli Corporate Summary
  7.19.2 China Meheco Kangli Business Overview
  7.19.3 China Meheco Kangli Sterile Infusions Compounding Pharmacy Major Product Offerings
  7.19.4 China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue in Global Market (2017-2022)
  7.19.5 China Meheco Kangli Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sterile Infusions Compounding Pharmacy Market Opportunities & Trends in Global Market
Table 2. Sterile Infusions Compounding Pharmacy Market Drivers in Global Market
Table 3. Sterile Infusions Compounding Pharmacy Market Restraints in Global Market
Table 4. Key Players of Sterile Infusions Compounding Pharmacy in Global Market
Table 5. Top Sterile Infusions Compounding Pharmacy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sterile Infusions Compounding Pharmacy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sterile Infusions Compounding Pharmacy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sterile Infusions Compounding Pharmacy Product Type
Table 9. List of Global Tier 1 Sterile Infusions Compounding Pharmacy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sterile Infusions Compounding Pharmacy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sterile Infusions Compounding Pharmacy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sterile Infusions Compounding Pharmacy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sterile Infusions Compounding Pharmacy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sterile Infusions Compounding Pharmacy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2023-2028
Table 30. Baxter Corporate Summary
Table 31. Baxter Sterile Infusions Compounding Pharmacy Product Offerings
Table 32. Baxter Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 33. B. Braun Corporate Summary
Table 34. B. Braun Sterile Infusions Compounding Pharmacy Product Offerings
Table 35. B. Braun Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Kabi Corporate Summary
Table 37. Fresenius Kabi Sterile Infusions Compounding Pharmacy Product Offerings
Table 38. Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 39. Kelun Pharma Corporate Summary
Table 40. Kelun Pharma Sterile Infusions Compounding Pharmacy Product Offerings
Table 41. Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 42. Otsuka Pharmaceutical Corporate Summary
Table 43. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 44. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 45. JW Pharmaceutical Corporate Summary
Table 46. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 47. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Sterile Infusions Compounding Pharmacy Product Offerings
Table 50. Pfizer Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Corporate Summary
Table 52. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 53. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 54. Haisco Pharmaceutical Group Corporate Summary
Table 55. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product Offerings
Table 56. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 57. King York Corporate Summary
Table 58. King York Sterile Infusions Compounding Pharmacy Product Offerings
Table 59. King York Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 60. Cisen Corporate Summary
Table 61. Cisen Sterile Infusions Compounding Pharmacy Product Offerings
Table 62. Cisen Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 63. Lummy Corporate Summary
Table 64. Lummy Sterile Infusions Compounding Pharmacy Product Offerings
Table 65. Lummy Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 66. Grand Life Sciences Corporate Summary
Table 67. Grand Life Sciences Sterile Infusions Compounding Pharmacy Product Offerings
Table 68. Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 69. Medisan Corporate Summary
Table 70. Medisan Sterile Infusions Compounding Pharmacy Product Offerings
Table 71. Medisan Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 72. BBCA Pharmaceutical Corporate Summary
Table 73. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 74. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 75. Biokin Pharmaceutical Corporate Summary
Table 76. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 77. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 78. Xi'an Libang Pharmaceutical Corporate Summary
Table 79. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 80. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 81. Lionco Pharmaceutical Corporate Summary
Table 82. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offerings
Table 83. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)
Table 84. China Meheco Kangli Corporate Summary
Table 85. China Meheco Kangli Sterile Infusions Compounding Pharmacy Product Offerings
Table 86. China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sterile Infusions Compounding Pharmacy Segment by Type in 2021
Figure 2. Sterile Infusions Compounding Pharmacy Segment by Application in 2021
Figure 3. Global Sterile Infusions Compounding Pharmacy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sterile Infusions Compounding Pharmacy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sterile Infusions Compounding Pharmacy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sterile Infusions Compounding Pharmacy Revenue in 2021
Figure 8. By Type - Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 12. US Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 16. Germany Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 17. France Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 24. China Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 28. India Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 30. Brazil Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sterile Infusions Compounding Pharmacy Revenue Market Share, 2017-2028
Figure 33. Turkey Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sterile Infusions Compounding Pharmacy Revenue, (US$, Mn), 2017-2028
Figure 37. Baxter Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. B. Braun Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. King York Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cisen Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lummy Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Medisan Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)